AVTX Avalo Therapeutics Inc.
Health Care, filed as AVALO THERAPEUTICS INC (COM NEW), Equity As of 2026 Q3 so far: 135 of 140 managers we track have filed Quote on Google Finance, opens in a new tab
In 2026 Q3 Farallon Capital Management added to Avalo Therapeutics.
Who owns this now
Largest portfolio weights among holders, up to 0.3% (Farallon Capital Management). Not free-float ownership.
Who owns AVTX
Sorted by value, long equity only, as of 2026 Q3.
| History | |||||
|---|---|---|---|---|---|
| Farallon Capital Management | Add +59.1% | 3,974,000 | $61M | History |
Insider trades
Open-market buys and sales by AVTX's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $52K sold by 1 insider outside a trading plan
- $8.3M sold by 4 insiders under 10b5-1 plans
-
Christopher Ryan Sullivan CFOPlanned sale$202K 12,394 shares at $16.33 24% of stakeTraded Sep 16 Filed Sep 18
-
Christopher Ryan Sullivan CFOPlanned sale$179K 10,185 shares at $17.62 20% of stakeTraded Sep 10 Filed Sep 11
-
Mittie Doyle Chief Medical OfficerPlanned sale$14K 679 shares at $20.00 1.3% of stakeTraded Aug 28 Filed Sep 1
-
Mittie Doyle Chief Medical OfficerPlanned sale$20K 1,000 shares at $20.00 1.9% of stakeTraded Aug 17 Filed Aug 19
-
Christopher Ryan Sullivan CFOPlanned sale$1.5M 72,725 shares at $19.94 65% of stakeTraded Aug 17–18 Filed Aug 19
-
Jennifer Riley Chief Strategy OfficerSale$52K 2,655 shares at $19.59 6.7% of stakeTraded Aug 11 Filed Aug 12
-
Mittie Doyle Chief Medical OfficerPlanned sale$14K 679 shares at $20.00 1.3% of stakeTraded Aug 10 Filed Aug 12
-
Mittie Doyle Chief Medical OfficerPlanned sale$20K 1,000 shares at $20.00 1.9% of stakeTraded Jul 27 Filed Jul 29
-
Mittie Doyle Chief Medical OfficerPlanned sale$93K 4,654 shares at $20.00 8.2% of stakeTraded Jun 30 Filed Jul 2
-
Mittie Doyle Chief Medical OfficerPlanned sale$26K 1,450 shares at $18.00 2.7% of stakeTraded Jun 23 Filed Jun 25
-
Mittie Doyle Chief Medical OfficerPlanned sale$11K 679 shares at $16.00 1.4% of stakeTraded May 28 Filed Jun 1
-
Mittie Doyle Chief Medical OfficerPlanned sale$56K 3,000 shares at $18.76 45% of stakeTraded May 15 Filed May 19
-
Christopher Ryan Sullivan CFOPlanned sale$449K 18,606 shares at $24.12 98% of stakeTraded May 7 Filed May 11
-
Mittie Doyle Chief Medical OfficerPlanned sale$2.2M 108,234 shares at $20.61 97% of stakeTraded May 5–6 Filed May 7
-
Christopher Ryan Sullivan CFOPlanned sale$949K 47,000 shares at $20.19 99% of stakeTraded May 6 Filed May 7
Also filed in the last 12 months, not counted as buying or selling: 33 option exercises, 10 share withholdings for taxes, and 5 stock grants.
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 424B5 | Filing Doc | ||
| 8-K | 1.01,1.02,9.01 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 424B3 | Filing Doc |
No filings match this filter.
Financials
US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.
Income statement
Balance sheet
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total current assets | $8.4M | $138.89M | $105.29M |
| Total non-current assets * | $12.6M | $11.84M | $11.17M |
| Total assets | $20.99M | $150.73M | $116.46M |
| Total current liabilities | $4.62M | $6.96M | $12.94M |
| Total non-current liabilities * | $9.07M | $10.74M | $20.47M |
| Total equity | $7.3M | $133.03M | $83.05M |
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon